AI predicting brain cancer relapse represents a significant advancement in the fight against pediatric gliomas, targeting the future of cancer recurrence prediction with unprecedented accuracy.Recent studies indicate that an innovative AI tool, designed to analyze multiple brain scans over time, outperforms traditional methods in identifying relapse risks among young patients.